dasatinib Index

Featured: dasatinib, Sprycel Main Article

Dasatinib (Sprycel) is a kinase inhibitor drug prescribed for the treatment of newly diagnosed Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML); treatment of chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib; and treatment of Ph+ acute lymphoblastic leukemia (ALL) with resistance or intolerance to prior therapy. Drug interactions, dosing, side effects, and warnings and precautions should be reviewed prior to taking any medication.


Related FAQs, Doctor's & Expert's Views

Health News

Tools & References

FDA Drug Labels on RxList.com

Terms related to dasatinib:

  • Sprycel